Imperial College London Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
University of Nottingham Featured PhD Programmes

Treatment of multi-drug resistant infections using a novel, rapid and customised synthetic phage therapy platform.

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  • Full or part time
    Dr Karen Weynberg
  • Application Deadline
    No more applications being accepted
  • Funded PhD Project (Students Worldwide)
    Funded PhD Project (Students Worldwide)

Project Description

Antimicrobial resistance is increasing at an alarming rate globally. Therefore, there is an urgent need to develop alternative, and potentially complementary, therapeutics to combat pathogenic microbes. The use of phage therapeutic methods in a variety of environments is poorly explored. This project aims to explore further the use of phage therapy by establishing an innovative synthetic biology platform to engineer phage therpay candidates within a biofoundry and will leverage the candidate’s skills in one or more of the following areas - microbiology, molecular biology, genetic engineering and laboratory automation. This project will focus on treating multi-drug resistant uropathogenic E. coli (UPEC), which is responsible for one of the most common illnesses - urinary tract infection - and is increasingly associated with antibiotic resistance. Successful outcomes of this project will be peer-reviewed publications in high-impact journals, intellectual property and the chance to make a positive difference in the lives of people chronically infected by UPEC pathogens.

Funding Notes

Australian and international applicants welcome. First class Honours/ Masters in a related discipline such as Microbiology, Molecular Biology, Bioengineering, or Virology required.

References

https://doi.org/10.1089/phage.2019.0005



FindAPhD. Copyright 2005-2020
All rights reserved.